Belgium - Immunoglobulins
For more information and to make a bid you will need to go to the third party website.
Details
Provided by- Opportunity closing date
- 16 August 2022
- Opportunity publication date
- 05 July 2022
- Category
- 33651520
- Value of contract
- to be confirmed
- Your guide to exporting
Description
Hospitals must purchase the portion not covered by the national government contract for processing plasma supplied by blood establishments in Belgium and ensuring adequate supply to hospitals of stable plasma derivatives (albumin solutions and immunoglobulins for intravenous administration) manufactured from the plasma supplied under the supervision of the FPS Public Health, Food Chain Safety and Environment (ref: FPS VVVL-PLASMADERIVATEN/2021/01-F03_0). To this end, the present framework agreement is being put on the market. The aim is to conclude a framework agreement not only for the supply of polyvalent human immunoglobulins but also for prothrombin complex concentrate and fibrinogen.
Concerns the purchase of low concentrated immunoglobulins <= 5% Concerns the purchase of polyvalent high concentrated ( >5%) immunoglobulins for iv for the northern hospital network of Limburg. Concerns the purchase of Polyvalent highly concentrated ( >5%) immunoglobulins for iv for the southern hospital network of Limburg. Concerns the purchase of Polyvalent highly concentrated (>5%) immunoglobulins for iv with IgA content < 20 micrograms/ml. Concerns the purchase of Protrombin complex concentrate. Concerns the purchase of phybrinogen.
- Opportunity closing date
- 16 August 2022
- Value of contract
- to be confirmed
About the buyer
- Address
- Hospilim VZW Bioville, Agoralaan Abis Diepenbeek 3590 Belgium
- Contact
- debbie.smets@hospilim.be
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.